Contemporary Atrial Fibrillation Management: A Comparison of the Current AHA/ACC/HRS, CCS, and ESC Guidelines.

Abstract

In this article we compare and contrast the current recommendations, and highlight the important differences, in the American College of Cardiology/American Heart Association/Heart Rhythm Society, European Society of Cardiology, and Canadian Cardiovascular Society atrial fibrillation (AF) guidelines. Although many of the recommendations of the various societies are similar, there are important differences in the methodologies underlying their development and the specific content. Specifically, key differences can be observed in: (1) the definition of nonvalvular AF, which subsequently affects anticoagulation choices and candidacy for non-vitamin K antagonist oral anticoagulants; (2) the symptom score used to guide management decisions and longitudinal patient profiling; (3) the stroke risk stratification algorithm used to determine indications for oral anticoagulant therapy; (4) the role of acetylsalicylic acid in stroke prevention in AF; (5) the antithrombotic regimens used in the context of coronary artery disease, acute coronary syndromes, and percutaneous coronary intervention; (6) the rate control target and medications recommended to achieve the target; and (7) the role of "first-line" catheter ablation, open surgical ablation, and left atrial appendage exclusion.

• Authors: Jason G Andrade, Laurent Macle, Stanley Nattel, Atul Verma, John Cairns
• Journal: The Canadian journal of cardiology (Can J Cardiol) Vol. 33 Issue 8 Pg. 965-976 (08 2017) ISSN: 1916-7075 [Electronic] England
• PMID: 28754397 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Topics

• American Heart Association
• Atrial Fibrillation (therapy)
• Canada
• Cardiology
• Disease Management
• Europe
• Humans
• Practice Guidelines as Topic
• Societies, Medical
• United States